Suppr超能文献

基于直接特征的用于尖端扭转型室性心动过速风险分层的新型两步分类器

Novel Two-Step Classifier for Torsades de Pointes Risk Stratification from Direct Features.

作者信息

Parikh Jaimit, Gurev Viatcheslav, Rice John J

机构信息

IBM T. J. Watson Research Center, Yorktown Heights, NY, United States.

出版信息

Front Pharmacol. 2017 Nov 14;8:816. doi: 10.3389/fphar.2017.00816. eCollection 2017.

Abstract

While pre-clinical Torsades de Pointes (TdP) risk classifiers had initially been based on drug-induced block of hERG potassium channels, it is now well established that improved risk prediction can be achieved by considering block of non-hERG ion channels. The current multi-channel TdP classifiers can be categorized into two classes. First, the classifiers that take as input the values of drug-induced block of ion channels (direct features). Second, the classifiers that are built on features extracted from output of the drug-induced multi-channel blockage simulations in the models (derived features). The classifiers built on derived features have thus far not consistently provided increased prediction accuracies, and hence casts doubt on the value of such approaches given the cost of including biophysical detail. Here, we propose a new two-step method for TdP risk classification, referred to as Multi-Channel Blockage at Early After Depolarization (MCB@EAD). In the first step, we classified the compound that produced insufficient hERG block as non-torsadogenic. In the second step, the role of non-hERG channels to modulate TdP risk are considered by constructing classifiers based on direct or derived features at critical hERG block concentrations that generates EADs in the computational cardiac cell models. MCB@EAD provides comparable or superior TdP risk classification of the drugs from the direct features in tests against published methods. TdP risk for the drugs highly correlated to the propensity to generate EADs in the model. However, the derived features of the biophysical models did not improve the predictive capability for TdP risk assessment.

摘要

虽然临床前尖端扭转型室速(TdP)风险分类器最初是基于药物对人乙醚相关基因(hERG)钾通道的阻滞,但现在已经明确,通过考虑对非hERG离子通道的阻滞可以实现更好的风险预测。当前的多通道TdP分类器可分为两类。第一类是将药物诱导的离子通道阻滞值(直接特征)作为输入的分类器。第二类是基于从模型中药物诱导的多通道阻滞模拟输出中提取的特征构建的分类器(派生特征)。基于派生特征构建的分类器迄今为止并没有始终如一地提高预测准确性,因此鉴于纳入生物物理细节的成本,人们对这种方法的价值产生了怀疑。在这里,我们提出了一种新的TdP风险分类两步法,称为去极化后早期多通道阻滞(MCB@EAD)。第一步,我们将产生hERG阻滞不足的化合物分类为非致TdP性。第二步,通过在计算心脏细胞模型中基于产生早期后去极化(EAD)的关键hERG阻滞浓度下的直接或派生特征构建分类器,来考虑非hERG通道对调节TdP风险的作用。在与已发表方法的测试中,MCB@EAD从直接特征对药物提供了相当或更好的TdP风险分类。药物的TdP风险与模型中产生EAD的倾向高度相关。然而,生物物理模型的派生特征并没有提高TdP风险评估的预测能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验